CF Industries
CF
$108.16
-0.09%
CF Industries Holding, Inc. is a leading global producer and distributor of nitrogen-based fertilizers, operating primarily in the Agricultural Inputs industry within the Basic Materials sector. The company's competitive identity is defined by its position as one of the world's lowest-cost nitrogen producers, leveraging low-cost U.S. natural gas as its primary feedstock. The current investor narrative is heavily driven by geopolitical events, specifically the closure of the Strait of Hormuz, which has stranded a significant portion of global fertilizer supply, creating a massive margin opportunity for North American producers like CF Industries with local inputs, as reflected in recent sharp price movements and analyst focus on the sector.…
CF
CF Industries
$108.16
Investment Opinion: Should I buy CF Today?
Rating & Thesis: Hold. CF Industries presents a high-risk, high-potential-reward value proposition that is currently out of favor, as the market prices in the end of a favorable cycle; investors should wait for clearer signs of earnings stabilization or a deeper valuation cushion before establishing new positions. This aligns with the mixed analyst sentiment, where recent actions show both downgrades and reaffirmations, reflecting the high uncertainty.
Supporting Evidence: The stock trades at a trailing PE of 8.62x and a forward PE of 8.97x, indicating no expected near-term growth, and at a significant discount based on its PEG ratio of 0.26. Profitability remains strong with a net margin of 21.58% in Q4 2025 and exceptional returns on equity of 30.07%. Furthermore, the company generates massive free cash flow ($1.80B TTM) and has a solid balance sheet (Current Ratio 3.37), providing fundamental resilience. However, these attractive metrics are counterbalanced by a -19.50% one-month price decline and a revenue trend that has plateaued after Q2 2025.
Risks & Conditions: The two biggest risks are a faster-than-expected decline in nitrogen fertilizer margins and a full reversal of the geopolitical premium, leading to earnings misses. This Hold rating would upgrade to a Buy if the stock price approaches the $75 support level (offering a larger margin of safety) or if quarterly gross margins demonstrate resilience above 40% for two consecutive quarters, signaling the downturn is less severe than feared. It would downgrade to a Sell if quarterly revenue growth turns negative or if the debt-to-equity ratio rises above 1.0 due to aggressive share buybacks at elevated prices. Based on current cyclical headwinds, the stock appears fairly valued to slightly overvalued relative to its near-term earnings trajectory, despite its cheap absolute multiples.
Sign up to view all
CF 12-Month Price Forecast
The outlook for CF is balanced but skewed with a downward bias. The base case (55% probability) of range-bound trading reflects the clash between undeniable fundamental value and clear cyclical headwinds. The company's financial fortress and low-cost position prevent a bearish stance, but the unwinding of the geopolitical narrative and terrible technicals argue against bullishness. The stance would upgrade to bullish if the stock holds above $95 on a quarterly basis while demonstrating gross margin stability, signaling the downturn is manageable. It would turn bearish if quarterly revenue declines sequentially and the stock breaks decisively below its $75.42 support, confirming a deeper cyclical slump.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CF Industries's 12-month outlook, with a consensus price target around $140.61 and implied upside of +30.0% versus the current price.
Average Target
$140.61
13 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
13
covering this stock
Price Range
$87 - $141
Analyst target range
The stock is covered by 13 analysts, indicating substantial institutional interest. The consensus recommendation sentiment appears mixed, as evidenced by recent institutional ratings which include actions like 'Underperform' from Mizuho and B of A Securities, 'Outperform' from BMO Capital, and 'Neutral' from CIBC and UBS. The average target price is not explicitly provided in the data, but analyst estimates point to an average EPS forecast of $7.36 for the coming period, with a range from $6.31 to $9.09, and average revenue estimates of $6.40 billion. The target price range implied by the EPS estimates, when combined with the current PE multiple, would be wide, signaling high uncertainty among analysts regarding the company's future earnings power. The high EPS target of $9.09 likely assumes sustained high nitrogen prices and margin expansion from the geopolitical supply shock, while the low target of $6.31 likely factors in a rapid normalization of fertilizer markets and margin compression. The recent pattern of analyst actions in March 2026 shows both reaffirmations and downgrades, with Mizuho moving from 'Neutral' to 'Underperform', reflecting a divergence in views on the sustainability of the current commodity environment.
Bulls vs Bears: CF Investment Factors
The investment debate for CF Industries is a classic clash between compelling value fundamentals and a deteriorating technical and narrative picture. The bull case is anchored in deep valuation metrics (PEG 0.26, PE 8.62x), exceptional profitability (ROE 30.07%), and a fortress balance sheet. The bear case is driven by the rapid unwinding of the geopolitical risk premium, severe price underperformance, and fears that the nitrogen cycle has peaked. Currently, the bearish evidence holds stronger sway, as the stock's price action and recent news flow directly contradict the bullish thesis that sustained high margins are achievable. The single most important tension is the sustainability of fertilizer margins and CF's earnings power now that the Hormuez supply shock has reversed; if margins stabilize near current levels, the stock is deeply undervalued, but if they mean-revert sharply, the low PE is a value trap.
Bullish
- Deeply Undervalued on PEG Ratio: The stock's PEG ratio of 0.26, based on trailing metrics, suggests it is significantly undervalued relative to its growth rate. This is a classic value signal, indicating the market is not pricing in the company's recent strong profitability and cash flow generation.
- Exceptional Profitability and Cash Flow: CF Industries maintains robust profitability with a trailing net margin of 20.54% and generated $1.80 billion in TTM free cash flow. This strong cash generation provides a financial cushion for downturns and funds strategic investments in blue/green ammonia without relying on external capital.
- Strong Balance Sheet with Low Leverage: The company's debt-to-equity ratio of 0.82 is manageable, and its current ratio of 3.37 indicates ample liquidity. This financial strength positions CF to navigate the volatile fertilizer cycle better than more leveraged peers and return capital to shareholders.
- Low-Cost Producer Advantage Intact: As one of the world's lowest-cost nitrogen producers using U.S. natural gas, CF's structural cost advantage remains a durable competitive moat. This is evidenced by its consistent gross margins, which were 41.08% in Q4 2025.
Bearish
- Severe Technical Downtrend and Underperformance: The stock is in a pronounced downtrend, down 19.50% over the past month and underperforming the S&P 500 by 32.73% over three months. Trading at 72.5% of its 52-week range, the momentum-driven geopolitical premium has fully reversed, indicating persistent selling pressure.
- Geopolitical Premium Unwinding Post-Hormuz: Recent news confirms the Strait of Hormuz has reopened, crushing the 'war premium' in related commodities. This directly undermines the core bullish narrative that drove CF's price to $141.96, as global fertilizer supply chains normalize and margin opportunities shrink.
- Revenue Plateau and Cyclical Peak Fears: Quarterly revenue peaked at $1.89B in Q2 2025 and was $1.87B in Q4 2025, indicating a plateau. With 22.83% YoY growth in Q4, deceleration is likely as the cycle turns, pressuring earnings estimates which already show high uncertainty (EPS range $6.31 to $9.09).
- Analyst Sentiment Turning Cautious: Recent analyst actions include downgrades to 'Underperform' (Mizuho), reflecting growing skepticism about the sustainability of the commodity upcycle. The mixed consensus among 13 analysts, with an average EPS estimate of $7.36, points to heightened uncertainty and lack of conviction.
CF Technical Analysis
The stock is in a pronounced downtrend from its recent highs, with a 1-year price change of only +2.61% significantly underperforming the S&P 500's +24.99% gain. As of the latest close of $102.93, the price is trading at approximately 72.5% of its 52-week range ($75.42 to $141.96), indicating a substantial retreat from peak levels and suggesting the momentum-driven rally has fully reversed. Recent momentum is decisively negative, with the stock down -19.50% over the past month and -17.59% over the past three months, a sharp divergence from its positive 6-month performance of +30.79% and signaling a significant trend reversal likely driven by the easing of geopolitical risk premiums. The stock's low beta of 0.382 indicates it has historically been far less volatile than the broader market, though recent price action suggests it is experiencing idiosyncratic, event-driven volatility tied to commodity price swings. Key technical support is anchored at the 52-week low of $75.42, while immediate resistance is at the recent high of $141.96. A breakdown below the $75.42 support would signal a complete unwinding of the geopolitical premium and a return to pre-crisis fundamentals, whereas a recovery above the $141.96 resistance seems unlikely without a renewed supply shock. The stock's maximum drawdown of -25.75% from its peak underscores the severe volatility experienced, and its low beta suggests the recent sell-off is a specific reaction to changing commodity dynamics rather than broad market weakness, which is critical for risk assessment in a concentrated portfolio. The stock's relative strength metrics are deeply negative, with a 1-month relative strength of -20.24 and a 1-year relative strength of -22.38 versus the S&P 500, confirming severe underperformance. The 3-month relative strength of -32.73 is particularly stark, highlighting the intensity of the recent sell-off. This technical weakness, combined with a short ratio of 3.03, indicates elevated bearish sentiment and potential for a short-covering rally if any positive catalyst emerges, but the prevailing trend remains firmly down.
Beta
0.38
0.38x market volatility
Max Drawdown
-25.8%
Largest decline past year
52-Week Range
$75-$142
Price range past year
Annual Return
+16.9%
Cumulative gain past year
| Period | CF Return | S&P 500 |
|---|---|---|
| 1m | -4.5% | -1.7% |
| 3m | -16.8% | +13.7% |
| 6m | +35.0% | +9.2% |
| 1y | +16.9% | +20.7% |
| ytd | +35.0% | +9.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CF Fundamental Analysis
Revenue growth has been robust but is decelerating from peak levels; the most recent Q4 2025 revenue was $1.87 billion, representing a strong year-over-year growth rate of 22.83%. However, examining the quarterly sequence from Q1 2025 ($1.66B) to Q4 2025 ($1.87B) shows revenue peaked in Q2 2025 at $1.89 billion, indicating the top-line may have plateaued. Segment data reveals Ammonia is the largest revenue driver at $708 million for the period, followed by UAN at $564 million, Urea at $372 million, and AN at $81 million, showing the business is diversified across nitrogen products. The company is highly profitable, with Q4 2025 net income of $404 million and a net margin of 21.58%. Gross margin for the quarter was a healthy 41.08%, and the trailing twelve-month net margin stands at 20.54%. Profitability has been stable but fluctuating with commodity cycles; for instance, gross margin has ranged from 38.10% in Q3 2025 to 44.76% in Q2 2025, demonstrating sensitivity to input costs and selling prices. The operating margin for Q4 2025 was 36.22%, indicating strong operational efficiency. The balance sheet is solid with a strong current ratio of 3.37 and a manageable debt-to-equity ratio of 0.816. The company generates substantial cash flow, with trailing twelve-month free cash flow of $1.80 billion, providing ample internal funding for growth initiatives and shareholder returns. Return on equity is exceptionally strong at 30.07%, and return on assets is a healthy 11.34%, indicating efficient use of capital. The robust free cash flow, coupled with a cash-heavy balance sheet, positions the company to weather commodity downturns and continue its strategic investments in blue and green ammonia.
Quarterly Revenue
$1.9B
2025-12
Revenue YoY Growth
+0.22%
YoY Comparison
Gross Margin
+0.41%
Latest Quarter
Free Cash Flow
$1.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CF Overvalued?
Given the company's substantial net income of $404 million in its latest quarter, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 8.62x, while the forward PE is slightly higher at 8.97x; the minimal gap suggests the market expects earnings to remain relatively stable in the near term, not anticipating significant growth acceleration. Compared to sector averages, CF Industries trades at a discount based on its EV/EBITDA multiple of 4.41x and its Price/Sales ratio of 1.77x. While direct industry average multiples are not provided in the data, the low single-digit EV/EBITDA and sub-2x PS ratio are typically indicative of a value-oriented, cyclical commodity stock rather than a growth company. The PEG ratio of 0.26, based on trailing metrics, suggests the stock is deeply undervalued relative to its growth rate, but this is common for cyclical peaks. Historically, the stock's current trailing PE of 8.62x sits near the lower end of its own historical range observed in the provided data, which has seen PEs as high as 25.15x in Q3 2023 and as low as 3.83x in Q2 2022. Trading near the bottom of its historical band suggests the market is pricing in a cyclical downturn or reduced expectations, potentially offering a value opportunity if the nitrogen cycle remains supportive, but also reflecting fears of margin compression from falling commodity prices.
PE
8.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -16x~25x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: CF Industries faces significant cyclicality risk inherent to the fertilizer business, where revenue and margins are directly tied to volatile commodity prices (natural gas input and nitrogen selling prices). The company's revenue plateau at ~$1.87B quarterly and gross margin fluctuation from 44.76% to 38.10% over recent quarters exemplify this earnings volatility. While the balance sheet is strong (D/E 0.82), the business model is not immune to a sharp downturn in the agricultural cycle, which could pressure the robust 20.54% net margin and the $1.80B annual FCF generation that supports its strategic initiatives and shareholder returns.
Market & Competitive Risks: The primary market risk is valuation compression. Despite trading at a low PE of 8.62x, the stock is near the bottom of its own historical PE band, having traded as high as 25.15x. If the market re-prices the stock for a full cyclical downturn, it could test its historical low multiples. Externally, the reopening of the Strait of Hormuz (as per April 2026 news) has removed a major geopolitical tailwind, normalizing global supply and threatening the margin advantage North American producers like CF briefly enjoyed. The stock's low beta of 0.382 offers little defense against these idiosyncratic, sector-specific headwinds.
Worst-Case Scenario: The worst-case scenario involves a rapid normalization of global fertilizer markets combined with a decline in agricultural demand, leading to a severe compression in nitrogen spreads. This would cause earnings to collapse toward the low end of analyst estimates ($6.31 EPS). In this adverse scenario, the stock could re-test its 52-week low of $75.42, representing a potential loss of approximately -27% from the current price of $102.93. A breach of this support could see the stock fall toward its historical crisis-level valuations, mirroring the PE of 3.83x seen in 2022, implying significantly further downside.
FAQ
The key risks are, in order of severity: 1) Commodity Cycle Risk: Earnings are highly sensitive to volatile nitrogen and natural gas prices; gross margins have fluctuated 6+ percentage points recently. 2) Geopolitical Normalization: The reopening of the Strait of Hormuz removes a major tailwind, threatening the margin advantage. 3) Technical Breakdown: The stock is in a severe downtrend, down 19.50% in a month, with key support at $75.42. 4) Analyst Downgrade Risk: Mixed sentiment could solidify into negative consensus if earnings deteriorate, as seen with Mizuho's recent move to Underperform.
The 12-month forecast is highly scenario-dependent. The base case (55% probability) sees the stock trading between $95 and $115 as earnings normalize toward the analyst average EPS of $7.36. The bull case (25% probability) targets a return to the $142+ range on sustained high margins and positive catalysts. The bear case (20% probability) warns of a drop toward the $75 support if the cycle turns sharply. The most likely outcome is range-bound trading, as the company's strong fundamentals buffer against a complete collapse, but cyclical headwinds prevent a sustained rally.
CF appears statistically undervalued on an absolute basis with a trailing PE of 8.62x and a PEG ratio of 0.26. However, context is critical: this PE is at the low end of its own historical range (3.83x to 25.15x), suggesting the market is pricing in a cyclical downturn. Compared to sector averages, its EV/EBITDA of 4.41x and P/S of 1.77x also suggest a value stock. The valuation implies the market expects earnings to decline, making it fairly valued to slightly overvalued relative to the near-term earnings trajectory, despite the cheap multiples.
CF is a contentious buy at current levels. For a patient, value-oriented investor willing to accept high volatility, its low PE of 8.62x, strong balance sheet, and cash generation present a compelling case if the fertilizer cycle is less severe than feared. However, given the sharp -19.50% monthly decline and the reversal of the key geopolitical catalyst, it carries significant near-term downside risk. It may be a good buy for those building a position gradually on further weakness, but not for investors seeking stability or short-term gains.
CF is unsuitable for short-term trading due to its event-driven volatility, low beta of 0.382 that masks recent idiosyncratic swings, and lack of near-term positive catalysts. It is a long-term investment for investors betting on the cyclical recovery of the fertilizer industry and the potential of its green ammonia initiatives. Given the cyclical nature, a minimum holding period of 3-5 years is suggested to potentially ride through the downturn and benefit from the eventual upswing. The modest 2.6% dividend yield provides a small income component while waiting.